A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG

Gemcitabine

DRUG

Cisplatinum

DRUG

Rituximab

Trial Locations (1)

Royal Marsden NHS trust, Sutton

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER